Current Perspectives on Methods for Administering Human Pluripotent Stem Cell-Derived Cells for Myocardial Repair

Jun Fujita, Keiichi Fukuda, Leslie W. Miller, Jianyi Zhang

研究成果: Chapter

抜粋

Human pluripotent stem cell (hPSC)-based therapies can be delivered as injection, as sheets of interconnected cells, or after suspending the cells in a scaffold of material that is designed to mimic the native extracellular matrix. The methods used to deliver cell therapy are being reviewed. The cell patch can be modified for the codelivery of peptides that may promote the survival and activate endogenous repair mechanisms. The scaffold-based approaches are currently suitable for applications that require thicker grafts, because the scaffold may be more readily vascularized by the host circulation. The effectiveness of hPSC therapy for myocardial repair can be enhanced by techniques that control inflammation, limit apoptosis, and improve vascular growth.

元の言語English
ホスト出版物のタイトルStem Cell and Gene Therapy for Cardiovascular Disease
出版者Elsevier Science Ltd.
ページ297-308
ページ数12
ISBN(電子版)9780128018637
ISBN(印刷物)9780128018880
DOI
出版物ステータスPublished - 2015 1 1

ASJC Scopus subject areas

  • Medicine(all)

フィンガープリント Current Perspectives on Methods for Administering Human Pluripotent Stem Cell-Derived Cells for Myocardial Repair' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Fujita, J., Fukuda, K., Miller, L. W., & Zhang, J. (2015). Current Perspectives on Methods for Administering Human Pluripotent Stem Cell-Derived Cells for Myocardial Repair. : Stem Cell and Gene Therapy for Cardiovascular Disease (pp. 297-308). Elsevier Science Ltd.. https://doi.org/10.1016/B978-0-12-801888-0.00024-2